These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36707788)

  • 41. Radiomics analysis based on single phase and different phase combinations of radiomics features from tri-phasic CT to distinguish renal oncocytoma from chromophobe renal cell carcinoma.
    Yang S; Jian Y; Yang F; Liu R; Zhang W; Wang J; Tan X; Wu J; Chen Y; Zhou X
    Abdom Radiol (NY); 2024 Jan; 49(1):182-191. PubMed ID: 37907684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative study of conventional ROI-based and volumetric histogram analysis derived from CT enhancement in differentiating malignant and benign renal tumors.
    Zhu Q; Zou J; Ye J; Zhu W; Wu J; Chen W
    Br J Radiol; 2022 Jul; 95(1135):20210801. PubMed ID: 35333594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors.
    Grajo JR; Terry RS; Ruoss J; Noennig BJ; Pavlinec JG; Bozorgmehri S; Crispen PL; Su LM
    Urology; 2019 Mar; 125():123-130. PubMed ID: 30552939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early dark cortical band sign on CT for differentiating clear cell renal cell carcinoma from fat poor angiomyolipoma and detecting peritumoral pseudocapsule.
    Ogawa Y; Morita S; Takagi T; Yoshida K; Tanabe K; Nagashima Y; Nishina Y; Sakai S
    Eur Radiol; 2021 Aug; 31(8):5990-5997. PubMed ID: 33559699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discrimination of oncocytoma and chromophobe renal cell carcinoma using MRI.
    Akın IB; Altay C; Güler E; Çamlıdağ İ; Harman M; Danacı M; Tuna B; Yörükoğlu K; Seçil M
    Diagn Interv Radiol; 2019 Jan; 25(1):5-13. PubMed ID: 30644365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The value of CT features and demographic data in the differential diagnosis of type 2 papillary renal cell carcinoma from fat-poor angiomyolipoma and oncocytoma.
    Zhou C; Ban X; Luo L; Shi C
    Abdom Radiol (NY); 2022 Nov; 47(11):3838-3846. PubMed ID: 36085376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis.
    Jinzaki M; Tanimoto A; Mukai M; Ikeda E; Kobayashi S; Yuasa Y; Narimatsu Y; Murai M
    J Comput Assist Tomogr; 2000; 24(6):835-42. PubMed ID: 11105696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Triphasic and epithelioid minimal fat renal angiomyolipoma and clear cell renal cell carcinoma: qualitative and quantitative CEUS characteristics and distinguishing features.
    Lu Q; Li CX; Huang BJ; Xue LY; Wang WP
    Abdom Imaging; 2015 Feb; 40(2):333-42. PubMed ID: 25139641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms.
    Choudhary S; Rajesh A; Mayer NJ; Mulcahy KA; Haroon A
    Clin Radiol; 2009 May; 64(5):517-22. PubMed ID: 19348848
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Usefulness of rapid kV-switching dual energy CT in renal tumor characterization.
    Çamlıdağ İ; Nural MS; Danacı M; Özden E
    Abdom Radiol (NY); 2019 May; 44(5):1841-1849. PubMed ID: 30637472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Qualitative and quantitative CECT features for differentiating renal primitive neuroectodermal tumor from the renal cell carcinoma and its subtypes.
    Kumar P; Singh A; Deshmukh A; Phulware RH; Rastogi S; Barwad A; Chandrashekhara SH; Singh V
    Br J Radiol; 2019 Feb; 92(1094):20180738. PubMed ID: 30362816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of aorta-lesion-attenuation difference on preoperative contrast-enhanced computed tomography scan to differentiate between malignant and benign oncocytic renal tumors.
    Grajo JR; Batra NV; Bozorgmehri S; Magnelli LL; Pavlinec J; O'Malley P; Su LM; Crispen PL
    Abdom Radiol (NY); 2021 Jul; 46(7):3269-3279. PubMed ID: 33665734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula.
    Kopp RP; Aganovic L; Palazzi KL; Cassidy FH; Sakamoto K; Derweesh IH
    Can J Urol; 2013 Jun; 20(3):6790-7. PubMed ID: 23783049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CT radiomics for differentiating oncocytoma from renal cell carcinomas: Systematic review and meta-analysis.
    Dehghani Firouzabadi F; Gopal N; Homayounieh F; Anari PY; Li X; Ball MW; Jones EC; Samimi S; Turkbey E; Malayeri AA
    Clin Imaging; 2023 Feb; 94():9-17. PubMed ID: 36459898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clear cell renal cell carcinoma: Machine learning-based computed tomography radiomics analysis for the prediction of WHO/ISUP grade.
    Shu J; Wen D; Xi Y; Xia Y; Cai Z; Xu W; Meng X; Liu B; Yin H
    Eur J Radiol; 2019 Dec; 121():108738. PubMed ID: 31756634
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of phase of enhancement on texture analysis in renal masses evaluated with non-contrast-enhanced, corticomedullary, and nephrographic phase-enhanced CT images.
    Nguyen K; Schieda N; James N; McInnes MDF; Wu M; Thornhill RE
    Eur Radiol; 2021 Mar; 31(3):1676-1686. PubMed ID: 32914197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A CT-based radiomics model for predicting renal capsule invasion in renal cell carcinoma.
    Yang L; Gao L; Arefan D; Tan Y; Dan H; Zhang J
    BMC Med Imaging; 2022 Jan; 22(1):15. PubMed ID: 35094674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility of multiphasic multidetector computed tomography in discriminating between clear cell renal cell carcinomas with high and low carbonic anhydrase-IX expression.
    Young JR; Coy H; Kim HJ; Douek M; Sisk A; Belldegrun A; Pantuck AJ; Raman SS
    Abdom Radiol (NY); 2018 Oct; 43(10):2734-2742. PubMed ID: 29520426
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis.
    Tordjman M; Mali R; Madelin G; Prabhu V; Kang SK
    Eur Radiol; 2020 Jul; 30(7):4023-4038. PubMed ID: 32144458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fuhrman nuclear grade prediction of clear cell renal cell carcinoma: influence of volume of interest delineation strategies on machine learning-based dynamic enhanced CT radiomics analysis.
    Luo S; Wei R; Lu S; Lai S; Wu J; Wu Z; Pang X; Wei X; Jiang X; Zhen X; Yang R
    Eur Radiol; 2022 Apr; 32(4):2340-2350. PubMed ID: 34636962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.